VF
PSTX

Virtu Financial’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History

Virtu Financial’s Portfolio PSTX Stock Details PSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,035
Closed -$37K – 2226
2024
Q3 		$37K Buy
+13,035
New +$40.4K ﹤0.01% 1051
2023
Q2 		– Sell
-22,806
Closed -$70K – 2180
2023
Q1 		$70K Buy
22,806
+5,017
+28% +$30.1K 0.01% 1047
2022
Q4 		$94K Buy
+17,789
New +$81.3K 0.01% 979

Other funds holding PSTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

Virtu Financial's PSTX Position: Q4 2024 in Review

Virtu Financial sold out of Poseida Therapeutics, Inc. Common Stock (PSTX) in Q4 2024, closing a stake of 13,035 shares — an estimated $37K sold.

Virtu Financial first reported a position in PSTX in Q4 2022 and held it in 3 quarters. The position peaked at $94K in Q4 2022. 115 funds tracked by Wall St. Rank hold PSTX as of Q4 2024.

  • Virtu Financial reported no remaining Poseida Therapeutics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Virtu Financial sold 13,035 Poseida Therapeutics, Inc. Common Stock shares in Q4 2024, an estimated $37K.
  • Virtu Financial first reported a position in Poseida Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
  • Virtu Financial's Poseida Therapeutics, Inc. Common Stock position peaked at $94K in Q4 2022.
  • 115 funds tracked by Wall St. Rank held Poseida Therapeutics, Inc. Common Stock as of Q4 2024.

Based on Virtu Financial's 13F filing for Q4 2024, filed 11 Feb 2025.